8.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Fennec Pharmaceuticals Reports Strong Q2 2025 Results and Expands Global Reach - TipRanks
How to manage a losing position in Fennec Pharmaceuticals Inc.July 2025 Action & Risk Managed Trade Strategies - Newser
Fennec Pharmaceuticals 2025 Q2 Earnings Narrowing Losses with 43.2% Net Income Improvement - AInvest
Will Fennec Pharmaceuticals Inc. stock go up soonInsider Buying & Expert Verified Stock Movement Alerts - Newser
Measuring Fennec Pharmaceuticals Inc.’s beta against major indicesWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
Fennec Pharmaceuticals Reports Strong Q2 2025 Growth - TipRanks
How Fennec Pharmaceuticals Inc. stock performs during market volatilityJuly 2025 Movers & Verified Chart Pattern Trade Signals - Newser
Fennec Pharmaceuticals Q2 2025: Unpacking Key Contradictions in Patient Adherence, Production Timelines, and Market Strategies - AInvest
What data driven models say about Fennec Pharmaceuticals Inc.’s futureShare Buyback & Free Reliable Trade Execution Plans - Newser
Fennec Q2 Sales Jump 33 Percent - The Motley Fool
Transcript : Fennec Pharmaceuticals Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: Fennec Pharmaceuticals Q2 2025 results disappoint - Investing.com
Fennec Pharmaceuticals Q2 Net Loss Narrows as Revenue Advances - 富途牛牛
Fennec Pharmaceuticals Sees Strong Q2 Growth and Expands Global Reach - TipRanks
Fennec Pharmaceuticals reports second quarter 2025 financial results - MarketScreener
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update - The Manila Times
Fennec Pharmaceuticals: Leveraging PEDMARK's Triple Drivers for Long-Term Value in a Niche Oncology Market - AInvest
Fennec Pharmaceuticals Q2 Revenue Beats Expectations, GAAP EPS Misses - AInvest
Applying chart zones and confluence areas to Fennec Pharmaceuticals Inc.Entry Point & High Return Stock Watch Alerts - Newser
Using data filters to optimize entry into Fennec Pharmaceuticals Inc.July 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser
Why Fennec Pharmaceuticals Inc. is moving todayPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
Can trapped investors hope for a rebound in Fennec Pharmaceuticals Inc.Weekly Stock Report & Community Consensus Stock Picks - Newser
How to interpret RSI for Fennec Pharmaceuticals Inc. stockWeekly Stock Recap & Weekly Setup with ROI Potential - Newser
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attention [2025 Historical Comparison]Community Trade Idea Sharing - Newser
Fennec Pharmaceuticals Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Fennec Pharmaceuticals FENC 2025Q2 Earnings Preview Downside Risk Amid Product Vulnerabilities - AInvest
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025 - The Manila Times
Fennec Pharmaceuticals to announce Q2 2025 financial results on Aug. 14. - AInvest
Fennec Pharmaceuticals Sets Q2 Earnings Date: Specialty Pharma Company to Update Investors August 14 - Stock Titan
Fennec Pharmaceuticals Inc. stock outlook for YEAREarly Entry Ideas with Momentum Potential - Newser
Real time pattern detection on Fennec Pharmaceuticals Inc. stockDividend Strategy Summary With 10-Year Outlook - Newser
Adherex Technologies (FENC) to Release Earnings on Tuesday - Defense World
What makes Fennec Pharmaceuticals Inc. stock price move sharplyShort-Term Swing Opportunity Summary Sheet - Newser
Fennec Pharmaceuticals FENC Q2 2025 Earnings Preview Downside Concerns Amid Product Vulnerability Issues - AInvest
Full technical analysis of Fennec Pharmaceuticals Inc. stockPredictive Model for Intraday Swing Forecast - Newser
Anterix Holds Virtual Annual Stockholders Meeting - The Globe and Mail
Paymentus Holdings: Strong Growth and Raised Guidance - The Globe and Mail
Evaluating Fennec Pharmaceuticals Inc. with trendline analysisCapital Protection Strategy With Risk Analysis - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):